Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Differential transcriptional responses to interferon-alpha and interferon-gamma in primary human hepatocytes.

He XS, Nanda S, Ji X, Calderon-Rodriguez GM, Greenberg HB, Liang TJ.

J Interferon Cytokine Res. 2010 May;30(5):311-20. doi: 10.1089/jir.2009.0082.

2.

Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes.

Radaeva S, Jaruga B, Hong F, Kim WH, Fan S, Cai H, Strom S, Liu Y, El-Assal O, Gao B.

Gastroenterology. 2002 Apr;122(4):1020-34.

PMID:
11910354
3.

Antiviral activity and host gene induction by tamarin and marmoset interferon-alpha and interferon-gamma in the GBV-B primary hepatocyte culture model.

Chavez D, Guerra B, Lanford RE.

Virology. 2009 Aug 1;390(2):186-96. doi: 10.1016/j.virol.2009.05.005. Epub 2009 Jun 7.

4.

Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus.

Jilg N, Lin W, Hong J, Schaefer EA, Wolski D, Meixong J, Goto K, Brisac C, Chusri P, Fusco DN, Chevaliez S, Luther J, Kumthip K, Urban TJ, Peng LF, Lauer GM, Chung RT.

Hepatology. 2014 Apr;59(4):1250-61. doi: 10.1002/hep.26653. Epub 2014 Feb 14.

5.

Genomic response to interferon-alpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics.

Lanford RE, Guerra B, Lee H, Chavez D, Brasky KM, Bigger CB.

Hepatology. 2006 May;43(5):961-72.

PMID:
16628626
6.

Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon.

Xiong W, Wang X, Liu XY, Xiang L, Zheng LJ, Liu JX, Yuan ZH.

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Dec;35(12):1053-60.

7.

Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.

Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, Kaul A, Zeuge U, Windisch MP, Trippler M, Lohmann V, Binder M, Frese M, Bartenschlager R.

Hepatology. 2012 Dec;56(6):2082-93. doi: 10.1002/hep.25908. Epub 2012 Oct 14.

PMID:
22711689
8.

Negative regulation of the interferon response by an interferon-induced long non-coding RNA.

Kambara H, Niazi F, Kostadinova L, Moonka DK, Siegel CT, Post AB, Carnero E, Barriocanal M, Fortes P, Anthony DD, Valadkhan S.

Nucleic Acids Res. 2014;42(16):10668-80. doi: 10.1093/nar/gku713. Epub 2014 Aug 13.

9.

Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-alpha or IFN-gamma.

Zocco MA, Carloni E, Pescatori M, Saulnier N, Lupascu A, Nista EC, Novi M, Candelli M, Cimica V, Mihm S, Gasbarrini G, Ramadori G, Gasbarrini A.

Dig Liver Dis. 2006 Aug;38(8):563-77. Epub 2006 Jun 27.

PMID:
16807150
10.

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes.

Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R, Storey H, Yao L, Liu H, Barahmand-pour F, Sivakumar P, Chan C, Birks C, Foster D, Clegg CH, Wietzke-Braun P, Mihm S, Klucher KM.

Hepatology. 2006 Oct;44(4):896-906.

PMID:
17006906
11.

Conditional expression of IFN-alpha and IFN-gamma activated by HBV as genetic therapy for hepatitis B.

Matskevich AA, Cordelier P, Strayer DS.

J Interferon Cytokine Res. 2003 Dec;23(12):709-21.

PMID:
14769147
12.

Critical role of interferon-α constitutively produced in human hepatocytes in response to RNA virus infection.

Tsugawa Y, Kato H, Fujita T, Shimotohno K, Hijikata M.

PLoS One. 2014 Feb 26;9(2):e89869. doi: 10.1371/journal.pone.0089869. eCollection 2014.

13.

Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection.

Gunduz F, Mallikarjun C, Balart LA, Dash S.

Exp Mol Pathol. 2014 Feb;96(1):36-41. doi: 10.1016/j.yexmp.2013.10.016. Epub 2013 Nov 8.

14.

Treatment with human gamma interferon of chronic hepatitis B: comparative study with alpha interferon.

Kakumu S, Ishikawa T, Mizokami M, Orido E, Yoshioka K, Wakita T, Yamamoto M.

J Med Virol. 1991 Sep;35(1):32-7.

PMID:
1940881
15.

Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.

Alvarado Esquivel C, Elewaut A, Philippé J, Elewaut AE, Desombere I, Maertens G, Leroux-Roels G.

Rev Invest Clin. 2002 Jan-Feb;54(1):41-50.

PMID:
11995406
16.

Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.

Bolen CR, Ding S, Robek MD, Kleinstein SH.

Hepatology. 2014 Apr;59(4):1262-72. doi: 10.1002/hep.26657. Epub 2014 Feb 18.

17.

Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein.

Geiss GK, Carter VS, He Y, Kwieciszewski BK, Holzman T, Korth MJ, Lazaro CA, Fausto N, Bumgarner RE, Katze MG.

J Virol. 2003 Jun;77(11):6367-75.

18.

Global transcriptional profiling demonstrates the combination of type I and type II interferon enhances antiviral and immune responses at clinically relevant doses.

Tan H, Derrick J, Hong J, Sanda C, Grosse WM, Edenberg HJ, Taylor M, Seiwert S, Blatt LM.

J Interferon Cytokine Res. 2005 Oct;25(10):632-49.

PMID:
16241862
20.

Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.

Murao K, Imachi H, Yu X, Cao WM, Nishiuchi T, Chen K, Li J, Ahmed RA, Wong NC, Ishida T.

Gut. 2008 May;57(5):664-71. Epub 2007 Nov 12.

PMID:
17998316

Supplemental Content

Support Center